Trade Summary

6 days ago, Sabag Mark, serving as See "Remarks" at Teva Pharmaceutical Industries Ltd (TEVA), sold 62,102 shares at $30.14 per share, for a total transaction value of $1,871,816.00. Following this transaction, Sabag Mark now holds 224,940 shares of TEVA.

This sale represents a 22.00% decrease in Sabag Mark's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.